Pharma developer takes 109K sf in Times Square

Schrödinger’s expansion is good sign for struggling office market

New York /
Apr.April 26, 2021 10:30 AM
Schrödinger President and CEO Ramy Farid and 1540 Broadway (Eden, Janine and Jim/Flickr, Schrödinger)

Schrödinger President and CEO Ramy Farid and 1540 Broadway (Eden, Janine and Jim/Flickr, Schrödinger)

A Midtown office building just snagged a tenant for a big lease.

Pharmaceutical developer Schrödinger inked a deal for nearly 109,000 square feet at Edge Fund Advisors’ 1540 Broadway, the New York Post reported. The company will occupy the 21st to 24th floors of the Times Square tower, which recently underwent a $40 million makeover that includes a 27,000-square-foot amenity center.

The company is moving from a 63,000-square-foot space at Kamber Management Company’s 120 West 45th Street.

Schrödinger got a good deal on the lease: It includes 16 months of free rent, according to the Post. Its rent reportedly starts in the $70s per square foot, and will rise over the 17-year lease term.

Cushman & Wakefield’s Peter Van Duyne and Alex Lachmund represented the tenant, per the report, and CBRE’s team led by Howard Fiddle and Eric Deutsch represented the landlord.

Schrödinger’s plan to expand in the middle of Times Square sends a much-needed positive sign in Manhattan’s office real estate market. The availability rate in Manhattan hit a record high of 16 percent in the first quarter, according to Colliers International. In addition, out of about 120 global tech companies that participated in a recent survey by Savills, 47 percent said they would need less space when they go back to office in the post-pandemic world.

The biggest leases signed during the first quarter include Blackstone’s 720,000-square-foot renewal at Rudin’s 345 Park Avenue, and Icahn School of Medicine at Mount Sinai’s 167,348-square-foot lease at Georgetown Company’s 787 Eleventh Avenue.

[NYP] — Akiko Matsuda





    Related Articles

    arrow_forward_ios
    With major financial choices to make, Newmark receives $850M infusion
    With major financial choices to make, Newmark receives $850M infusion
    With major financial choices to make, Newmark receives $850M infusion
    John Kilroy and the Indeed Tower (Getty, Page Southerland Page)
    Kilroy Realty buying Indeed Tower in Austin for $580M
    Kilroy Realty buying Indeed Tower in Austin for $580M
    Josh Baumgarten (left) and Adam Schwartz, co-CEOs and co-Chief Investment Officers of Angelo Gordon with 2 Huntington Quadrangle, Melville, 6 and 8 Corporate Center Drive in Melville (Angelo Gordon, We're Group)
    Angelo Gordon, We’re Group score $350M refi for Long Island offices
    Angelo Gordon, We’re Group score $350M refi for Long Island offices
    NYC’s office sublease surge slows as tenants move to reoccupy space
    NYC’s office sublease surge slows as tenants move to reoccupy space
    NYC’s office sublease surge slows as tenants move to reoccupy space
    The Roger New York hotel at 131 Madison Avenue, Larry Korman of AKA Hotel Residences and Joe Lubeck of Electra America (Google Maps, Getty, Electra)
    Electra America JV nabs Roger hotel for $71M discount
    Electra America JV nabs Roger hotel for $71M discount
    Oceanwide’s US business is sinking. Can it right the ship?
    Oceanwide’s US business is sinking. Can it right the ship?
    Oceanwide’s US business is sinking. Can it right the ship?
    Demir Sabanci and 41-47 West 57th Street (Sedesco, Google Maps)
    Sedesco seeks rezoning for new Billionaires’ Row skyscraper
    Sedesco seeks rezoning for new Billionaires’ Row skyscraper
    Brookfield Property Partners CEO Brian Kingston and 300 Vesey Street, at far left (Brookfield)
    Brookfield scores $224M refi on Battery Park office tower
    Brookfield scores $224M refi on Battery Park office tower
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...